AVIRAGEN THERAPEUTICS
Aviragen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases. The Company currently has two Phase 2 clinical-stage product candidates: laninamivir octanoate, which the Company is developing for the treatment of influenza A and B infections in the United States. through a contract with the U.S. Office of Biomedical Advanced Research and Development Authority (BARDA)... that provides up to $231 million in financial support to complete its clinical development; and vapendavir, a potent, oral broad spectrum capsid inhibitor of enteroviruses, including human rhinovirus. In addition to these clinical-stage development programs, the Company has preclinical programs focused on developing treatments for respiratory syncytial virus.
AVIRAGEN THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
1984-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.aviragentherapeutics.com
Total Employee:
51+
Status:
Closed
Contact:
678-221-3343
Email Addresses:
[email protected]
Technology used in webpage:
Google Maps IPv6 Microsoft Exchange Online Office 365 Mail Google Maps API Akamai Hosted Barracuda Networks
Similar Organizations
SelectX Pharmaceuticals Inc.
SelectX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of aminoglycoside therapeutics.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-06-03 | Anaconda Pharma | Anaconda Pharma acquired by Aviragen Therapeutics | N/A |
| 2012-04-23 | Nabi Biopharmaceuticals | Nabi Biopharmaceuticals acquired by Aviragen Therapeutics | N/A |
Official Site Inspections
http://www.aviragentherapeutics.com
Unable to get host informations!!!
More informations about "Aviragen Therapeutics"
Aviragen Therapeutics - Crunchbase Company Profile …
Aviragen Therapeutics, Inc. is a biopharmaceutical company focused on the …See details»
Aviragen Therapeutics - PitchBook
Aviragen Therapeutics General Information Description. Developer of direct …See details»
Organization | Aviragen Therapeutics
Organization Overview. First Clinical Trial. 2007 NCT00311714. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Aviragen Therapeutics, Inc. | Biota Holdings Ltd | …See details»
Aviragen Therapeutics - LinkedIn
Aviragen Therapeutics | 1,553 followers on LinkedIn. Aviragen Therapeutics was acquired by Vaxart in 2017 and was focused on the discovery and development of the next generation of …See details»
Aviragen Therapeutics Information - RocketReach
Aviragen Therapeutics was acquired by Vaxart in 2017 and was focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have …See details»
Aviragen Therapeutics Company Profile | Management and
Aviragen Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic options …See details»
Aviragen Therapeutics - Craft
Aug 4, 2022 Aviragen Therapeutics, formerly Biota Pharmaceuticals, is a biopharmaceutical company. The Company is focused on the discovery and development of direct-acting …See details»
Aviragen Therapeutics - Products, Competitors, Financials, …
Aviragen Therapeutics is a biopharmaceutical company that focuses on the discovery and development of next-generation antivirals. Use the CB Insights Platform to explore Aviragen …See details»
Aviragen Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
May 7, 2025 Explore Aviragen Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 37 clinical trials, 11 news, and 72 literature, Disease Domain:Infectious …See details»
Aviragen Therapeutics Company Overview, Contact Details
Aviragen Therapeutics is focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a …See details»
AVIRAGEN THERAPEUTICS - Profile, contacts and insights | The
Apr 19, 2000 Aviragen Therapeutics was acquired by Vaxart in 2017 and was focused on the discovery and development of the next generation of direct-acting antivirals to treat infections …See details»
Aviragen Therapeutics | LinkedIn
Aviragen Therapeutics | 1.554 Follower:innen auf LinkedIn. Aviragen Therapeutics was acquired by Vaxart in 2017 and was focused on the discovery and development of the next generation …See details»
Aviragen Therapeutics - Profiles & Contacts - Crunchbase
Aviragen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent . New. Resources. Advanced Search. Start Free Trial . …See details»
Aviragen Therapeutics Overview | SignalHire Company Profile
To connect with Aviragen Therapeutics employee register on SignalHire. Organization Website. aviragentherapeutics.com . Social Links. Phone Number. 1 650 550 3500,678-221-3343. …See details»
Aviragen Therapeutics - Drug pipelines, Patents, Clinical trials
May 7, 2025 Explore Aviragen Therapeutics with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news, Disease Domain:Infectious Diseases, Technology ...See details»
Aviragen Therapeutics - VentureRadar
Aviragen Therapeutics® is focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a …See details»
Aviragen Therapeutics Management Team | Org Chart
Top Aviragen Therapeutics Management Employees Eu Uday Patel Vice President - Regulatory Affairs at Aviragen Therapeutics Alpharetta, Georgia, United States View. 2 …See details»
Biota Pharmaceuticals, Inc. Announces Name Change to
Apr 12, 2016 Contacts: Mark Colonnese Executive Vice President and Chief Financial Officer Aviragen Therapeutics, Inc. (678) 221-3381 [email protected] Beth …See details»
Governance Aviragen Therapeutics Inc Nasdaq
Oct 24, 2019 Find the composition of the Board of Directors of Aviragen Therapeutics Inc (Nasdaq Stock Exchange), the gender parity as well as the age distribution of the insiders. ...See details»
Biota Pharma (BOTA) Becomes Aviragen Therapeutics; Will Trade …
Apr 12, 2016 Biota Pharmaceuticals, Inc. (Nasdaq: BOTA) announced that the Company has changed its name to Aviragen Therapeutics, Inc., (Aviragen Therapeutics), a pharmaceutical …See details»